Chard Daniel R 4

What Happened
Daniel R. Chard, Medifast’s Chairman & CEO, had a mix of transactions reported for mid-March 2026. He purchased 17,678 shares on the open market at an average price of $10.11 for about $178,725. He also received 41,795 shares through awards/vests (36,968 RSUs granted and 4,827 shares issued upon PSU vesting) valued at $0 on grant/settlement. To cover withholding tax obligations on vesting, a total of 29,808 shares were surrendered/withheld (7,075; 2,638; 20,095) for aggregate proceeds of roughly $287,285 (prices ranged around $9.59–$10.05).

Key Details

• Transaction dates: Mar 13, Mar 17, Mar 20, Mar 25, 2026. Filing date: Mar 27, 2026.
• Purchases: 17,678 shares on 2026-03-20 at a weighted average ~$10.11 (total ≈ $178,725). Footnote indicates purchase prices ranged $10.04–$10.18.
• Disposals (tax withholding): 7,075 shares @ $9.62 (Mar 13) = $68,062; 2,638 shares @ $10.05 (Mar 17) = $26,512; 20,095 shares @ $9.59 (Mar 25) = $192,711. Total withheld/sold ≈ 29,808 shares ≈ $287,285.
• Awards/Vests: 36,968 RSUs granted (vesting schedule noted in filing) and 4,827 shares issued upon vesting of performance stock units (PSUs) previously granted Mar 17, 2023; PSU awards were earned per Compensation Committee certification on Feb 5, 2026.
• Footnotes of note: F1 = shares withheld to satisfy tax withholding at vesting; F2 = weighted average purchase price across multiple transactions; F5 describes RSU vesting schedule; F6 describes PSU settlement on achievement of performance goals. Some holdings are noted as held in a joint account or family trust in the filing.
• Shares owned after transaction: not specified in the excerpt provided — check the full Form 4 for post-transaction beneficial ownership.
• Timeliness: Filed Mar 27, 2026 for transactions between Mar 13–Mar 25. Form 4s are typically due within two business days of a transaction; some earlier trades (Mar 13, Mar 17) appear to be reported after that two-business-day window.

Context

• Purchases (P) are generally considered more informative than routine tax-withholding disposals — Chard’s open-market buy of ~17.7k shares is a direct purchase.
• The disposals here are labeled as tax-withholding (F) tied to RSU/PSU vesting, not necessarily discretionary sales; these are routine and common when equity awards vest.
• The 4,827 shares reflect PSUs that vested based on previously set performance criteria (certified Feb 5, 2026), while the 36,968 RSUs are a grant with multi-year vesting.
• For full context (post-transaction ownership, exact footnote mappings, and any late-filing disclosures), consult the complete SEC Form 4 (Accession 0001628280-26-021795).